What's new

On 19 September 2018, at the International Atomic Energy Agency (IAEA) General Conference in Vienna, ARPANSA’s Deputy Chief Executive Officer, Gillian Hirth, alongside the Deputy Chairman of the Board of the Dutch Authority for Nuclear Safety and Radiation Protection (ANVS), Marco Brugmans, signed a memorandum of understanding (MoU).

ARPANSA has been busy building a new bunker in preparation for the installation of a new, state-of-the-art medical linear accelerator (linac)

On 29 June 2018, the CEO of ARPANSA, Dr Carl-Magnus Larsson, issued the Australian Nuclear Science and Technology Organisation with a direction under section 41(1A) of the Australian Radiation Protection and Nuclear Safety Act 1998.

We are establishing a network of radiation detectors to monitor Australian ports to assist in the national preparedness for a visiting nuclear-powered warship accident.

The International Commission on Non-Ionizing Radiation Protection has published draft guidelines for public consultation. ARPANSA is revising its Radiofrequency Standard and will consider the ICNIRP guidelines in this process.

Aircrew are exposed to elevated levels of cosmic radiation while flying at high altitudes. A recent study from the Harvard T.H. Chan School of Public Health in the United States found that the prevalence of certain cancers in flight attendants was higher than the general population.

An article published in the Daily Mail Australia on 18 June 2018, reports that using a mobile phone can be as damaging on your skin as being out in the sun. It is concerning that the exposure from smartphones has been compared to the same time spent in the sun.

Starting on Monday 4 June and continuing this week, ARPANSA, in collaboration with the International Atomic Energy Agency, hosts a Regional Training Course on Radiochemical Analysis of Marine Environmental Samples.

On 24-25 May 2018, ARPANSA and the International Atomic Energy Agency hosted an Asia-Pacific region workshop on the Establishment and Maintenance of a National Dose Registry for those who work with radiation as part of their jobs.

<p>We are a proud bronze sponsor of the fifth Asian and Oceanic International Radiation Protection Association Regional Congress on Radiation Protection (AOCRP5), hosted in Melbourne this week.</p>

ARPANSA’s CEO, Dr Carl-Magnus Larsson has issued a licence to the Australian Nuclear Science and Technology Organisation (ANSTO) to operate the ANSTO Nuclear Medicine Molybdenum-99 (Mo-99) Facility (the ANM Facility).

On Monday 26 February 2018 a report by the CEO of ARPANSA, Dr Carl-Magnus Larsson, was tabled in Parliament addressing the radiation exposure of a worker at the Australian Nuclear Science and Technology Organisation (ANSTO) Health radiopharmaceuticals production facility at Lucas Heights.

A series of animal studies on mobile phone radiofrequency radiation and health have been conducted over two years by the United States Department of Health and Human Services National Toxicology Program.

The International Commission on Radiological Protection have re-evaluated how they estimate lung cancer risk for exposure to radon progeny and doubled its estimate of risk from exposure.

We are hiring for the position of Chief Regulatory Officer and Head of Regulatory Services Branch.